----------------------- Advertisement --------------------------
Home » Experts » Dr Jame Abraham
Expert Profile

Dr Jame Abraham

Bonnie Wells Wilson Distinguished Professor and Eminent Scholar
West Virginia University
Morgantown, WV 26506-9162
Tuesday, November 02, 2010

Background:
Dr. Abraham is the first Bonnie Wells Wilson and Distinguished Professor and Eminent Scholar in Breast Cancer Research at MBRCC. He did his Fellowship in Hematology/Oncology at the National Cancer Institute (NCI) and National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH), Bethesda, MD. He did his residency at School of Medicine, University of Connecticut, CT and medical degree at Calicut Medical College in India.

Research Focus:
Dr. Abraham is dedicated to research in breast cancer diagnosis and treatment. He is the co-leader of the breast cancer program at MBRCC.

At the National Cancer Institute (www.cancer.gov), he did studies on novel drugs reversing multi-drug resistance. He was the study chairman of one of the early phase I clinical trials on epothilone B analogue BMS 247550(Ixempra®), which was eventually approved by FDA for metastatic breast cancer.

He is a member of Breast Cancer Working Group of National Surgical and Adjuvant Bowel Project (NSABP, www.nsabp.pitt.edu) and is on the board of directors of the South Atlantic Division of the American Cancer Society (www.cancer.org).

He is the Principal Investigator (PI) for more than 15 clinical trials at the Cancer Center. He is the Institutional PI for all the Eastern Cooperative Oncology Group (ECOG) and NSABP clinical trials. His translational research is focused on understanding the pathophysiology of chemotherapy induced cognitive dysfunction. His group has made notable contributions in preclinical, clinical and genomic understanding of “chemobrain”.

Dr. Abraham is the founding editor of Bethesda Handbook of Clinical Oncology, (3rd edition) (Lippincott Williams and Wilkins 2001, 2005 and 2009) a 700 page text book in Hematology-oncology. It is one of the best selling small textbooks in Oncology worldwide. Dr. Abraham is the chief editor of the Emerging Cancer Therapeutics series published by Demos publication, New York. He is also the editor of Breast Cancer: a Clinical Guide (Lippincott Williams and Wilkins, 2007). He is on the editorial boards of several journals, including Community Oncology, Supportive Cancer Therapy, Oncology and Biotechnology News and Expert Review in Anti Cancer Therapy. Abraham has published scientific papers in many journals, including the Journal of Clinical Oncology, Annals of Internal Medicine, Clinical Cancer Research, Cancer and Bone Marrow Transplantation.

Dr. Abraham has received several awards including an award from the President of India (Vaidya Bhooshan 2010), Dean’s Award for Excellence in Clinical Medicine (2010), Quality Award by West Virginia University Hospitals (2010), Outstanding Faculty Award (2007) and Clinician of the Year Award (2006) by the Department of Medicine. He received the volunteer of the year award from the American Cancer Society (2007), Idea Award and Career Development Award from the Department of Defense (2002) and Merit Award from the American Society of Clinical Oncology (2001).

Over the past 9 years he has given more than 100 invited lectures on breast cancer in the U.S and abroad.

 
Queries Answerd by Dr Jame Abraham
Am I at risk of breast cancer?
Does my aunt need chemotherapy?
Can peripheral neuropathy lead to stroke?
What does my mother’s mastectomy indicate?
 
----------------------- Advertisement4 --------------------------
 
Latest Photos
 
 
Survey
Radiation and health outcomes

The effect radiation has on human health has been the subject of recent interest.